Sign up
Pharma Capital
EPIC: AVO
Market: LSE:AVO
GREY:AONCF
FRA:R3I1
52-week High/Low: 64.00p / 33.00p
Sector: Health Care, Equipment & Services
Market Cap: 73.94M
Website: www.avoplc.com

Advanced Oncotherapy is a specialist developer and provider of a breakthrough proton therapy system, the LIGHT system, which is the result of 25 years of work at CERN and ADAM.

Our focus is on developing and supplying technologies to maximise the destructive effect of radiation on tumours whilst minimising damage to the patient's healthy tissues.

Advanced Oncotherapy plc operates...

Advanced Oncotherapy PLC

www.avoplc.com

Interactive graph

col 3
col 4
col 5
col 6
View full AVO profile View Profile
Article

Advanced Oncotherapy on track

View All

Columns Including AVO

VIEW ALL

Market Reports Including AVO

VIEW ALL

Executive video interviews

VIEW ALL VIDEOS

© biotech Capital 2019

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.